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Abstract 
Crystallization-induced diastereoisomer transformation (CIDT) was successfully 
employed in the enantioselective synthesis of 2-alkyl-3-aryl-propan-1-amines. 
These products are seen as potentially useful building blocks in the field of 
asymmetric organic chemistry, notably for pharmaceutically relevant 
compounds. The procedure was based on a recently reported protocol for 
deracemization of dihydrocinnamic aldehydes in which enantiomerically 
enriched 1-(amino(phenyl)methyl)naphthalen-2-ol (Betti base) is employed as a 
resolving agent. Additionally, fenpropimorph, a biologically active substance 
which contains the 2-alkyl-3-aryl-propan-1-amine moiety was synthetized, as an 
attempt to assess the usefulness of the enantiomerically enriched amines.              
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1 Introduction 
1.1 Chirality and its relevance to biological systems 
Chirality is a spatial concept with a wide range of implications in science. By 
definition, an object is said is to be chiral when it cannot be superimposed onto 
its mirror image. Analogously, in chemistry, mirror image molecules that cannot 
be reciprocally superimposed by translation and rotation symmetry operations 
are chiral. These pairs of mirror image molecules are called enantiomers and 
constitute one of the main concerns in the field of stereochemistry. 
The capacity of enantiomers to rotate plane-polarized light was known even 
before their relation was comprehended. Some substances crystallize as 
enantiomerically pure crystals. In such cases, the chirality might be perceivable 
macroscopically and the mirror image crystals sorted by hand. This is what 
Louis Pasteur did in a series of experiments that greatly contributed to the 
debate on molecular asymmetry and early development of stereochemistry. By 
noticing the handedness and laboriously sorting the crystals of tartrate salts 
which deposited in the bottom of wine casks during fermentation, Pasteur 
prepared separate solutions of enantiomorphic crystals and verified their 
property of rotating plane-polarized light with the same intensity, but in opposite 
directions.1 Nearly contemporary debates on the geometry of carbon 
compounds would then ultimately lead to the acknowledgment of sp3 carbons 
bound to four different atoms or groups of atoms, or asymmetric carbons, as the 
main source of chirality in organic chemistry. 
Enantiomers present identical physical and chemical behavior, unless they are 
subjected to an interaction with another chiral medium. Biological systems are 
essentially chiral environments. Amino acids and saccharides, for instance, are 
most predominantly found in one of its enantiomeric forms in nature. Therefore, 
the interaction of chiral molecule with a given organism may greatly differ from 
that of its enantiomer pair. For that reason, the control over the stereochemistry 
of biologically active compounds if of particular importance. The distinct 
interactions of enantiomers in vivo may be perceived, for instance, in flavor, 
odor, toxicity and drug effectiveness.  Perhaps the most well-known example of 
distinct biological activity between a pair of enantiomers is that of thalidomide, a 
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sedative and antiemetic drug. Among other uses, thalidomide was widely 
prescribed to pregnant women to prevent morning sickness in the late 1950’s. 
Until its side effects became known and it was finally withdrawn from the 
market, thousands of children were born with birth defects due to its use. The 
teratogenicity of thalidomide has been attributed to its (S)-enantiomer.  
Citalopram a selective serotonin-reuptake inhibitor antidepressant, is marketed 
in both its racemic form and as the (S)-enantiomer (escitalopram), to which the 
therapeutic activity is mainly attributed. The (R)-enantiomer is not known for any 
specific side effects, but even in such cases both technical and pharmacological 
aspects may justify the development of enantiomerically pure formulations. 
First, the use of racemic mixture in which only one of its enantiomers is active 
represents a considerable waste of raw material. And second, pharmaceuticals 
are subjected to long term post-marketing research, which occasionally unveils 
previously unknown side effects and may ultimately lead to the withdrawal of a 
drug from the market.  
 
Figure 1. Citalopram enantiomers    
1.2 Separation of enantiomers 
Obtaining enantiomerically pure compounds from achiral or racemic precursors 
can be technically challenging and/or economically impracticable. This is 
currently one of the most important fields of research in organic chemistry and it 
has shown great advance in the past couple of decades. The methods through 
which it can be accomplished can be primarily divided into resolutions methods 
and stereoselective syntheses. Sometimes the underlying concepts overlap into 
hybrid processes.2   
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1.2.1 Resolution methods 
A resolution consists of separating a mixture of enantiomers into its constituents 
and it can be further divided into several methods. Total spontaneous resolution 
consists on the separation of enantiomers with no conversion into 
diastereoisomeric states. It is conceptually simple, but of limited practical 
application. Very specific criteria must be met, including intrinsic properties and 
experimental conditions. Some enantiomers crystallize as conglomerates, 
mechanical mixtures of enantiomerically pure crystals. This phenomenon can 
be pronounced to the point that enantiomorphic crystals are macroscopically 
sortable. More often, however, satisfactory separation is not so easily achieved. 
In such cases, preferential crystallization may be induced, for instance, by 
seeding a saturated solution of a racemate with one of its enantiomers. A 
conglomerate like crystallization, however, is equally necessary.2 
Nevertheless, enantiomers are most often resolved through their conversion 
into diastereoisomers via reaction with a chiral substance.2 Stereoisomers are 
molecules that present the same molecular formula and connectivity between 
atoms, but a different three-dimensional arrangement. Among them, those 
which are not superimposable mirror images are defined as diastereoisomers. 
For instance, a molecule with two asymmetric carbons as the only stereogenic 
elements and no plane of symmetry presents four stereoisomers (Figure 2). In 
this case, each pair of molecules will present particular relationship. If both 
asymmetric centers are inverted, the molecules will be mirror images and thus 
enantiomers. On the other hand, if only one of the chiral centers is inverted, 
their relation will be diastereoisomeric. 
  
Figure 2. Stereoisomers of the amino acid threonine and their isomeric relationship. 
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Even though diastereoisomers may present similar physical and chemical 
properties, they are for all purposes different molecules. That is precisely the 
reason why the conversion of a pair of enantiomers into diastereoisomers 
renders them more easily separable. The reaction between a racemic mixture of 
and an enantiomerically pure substance, for example, generates two or more 
diastereoisomers. This substance is called resolving agent and its choice 
should be based, among other factors, on the possibility of recovery of the initial 
product. The separation between diastereoisomers can rely, in principle, in 
various physical or chemical properties. The majority of resolutions mediated by 
diastereoisomers, however, are based on solubility differences.2 
Enantiomers can be alternatively separated by kinetic resolution. In this case, 
the reaction rates between a pair of enantiomers and a chiral reactant must be 
significantly different. The desired product is more commonly the one with the 
lower reaction rate, being directly recovered in its enantiomerically enriched 
form. Nonetheless, it is sometimes possible to recover its enantiomeric pair 
from the reaction product, which is a factor that should be considered if both are 
potentially useful. 
Chromatographic separation through high performance liquid chromatography 
(HPLC) or gas chromatography (GC) can also be employed. The control over 
several chromatographic parameters makes it a versatile technique. However, 
the scaling-up costs for preparative purposes, especially due to the need for 
chiral stationary phases, is one of the main disadvantages of this technique.   
1.2.2 Stereoselective synthesis 
Synthetic routes which produce exclusively or predominantly one among related 
stereoisomers fit the concept of stereoselective synthesis. When an 
enantiomerically enriched product is desired, a chiral element must be present 
at some stage of the process. The first approach is to use enantiomerically 
enriched substances as reactants or building blocks for more complex ones. 
The asymmetric elements are either conserved or inverted and avoiding 
racemization throughout the synthetic pathway should be a major concern. The 
chiral reactants can be naturally available or obtained from previously resolved 
racemic mixtures. 
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The second approach is asymmetric catalysis. The relation between two 
transition states involving a pair of enantiomers and a chiral catalyst are 
essentially diastereoisomeric. Therefore, they present different energies, which 
ideally allows kinetic control over the reactions (Figure 3). 
 
Figure 3. General vs. asymmetric catalysis.  
A: reactant as racemic mixture; B: non-chiral catalyst; C: enantiopure chiral catalyst; D: reaction product 
As in general catalysis, substoichiometric quantities of the catalyst are used. 
The nature of the catalyst may vary and the methods can be further divided into 
organocatalysis, biocatalysis and organometallic catalysis. The first employs 
small chiral organic molecules, either natural or synthetic. Asymmetric 
biocatalysis, in its turn, relies on the ability of biomolecules, notably enzymes, 
which are chiral catalysts par excellence, to induce stereoselective synthesis. 
The latter method employs chiral organometallic complexes as asymmetric 
catalysts. 
1.2.3 Dynamic resolutions and Crystallization Induced Diastereoisomer 
Transformation (CIDT) 
Classical resolutions are not asymmetric methods. In other words, they are 
limited to a 50% yield of a given enantiomer. Dynamic resolutions, on the other 
hand, allow the conversion of both enantiomers from a racemate into a single 
stereoisomer. These processes rely on the interconversion between optically 
labile molecules, either the enantiomers themselves or diastereoisomeric 
intermediate, and on a concomitant equilibrium displacement factor. 
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Crystallization-induced enantiomer transformation (CIET) is the dynamic 
variation of total spontaneous resolution. Therefore, the same constraints apply. 
The compound must crystallize as a conglomerate and very specific 
experimental conditions might be necessary. Enantiopure seeds, for instance, 
can be used to induce preferential crystallization and the concomitant 
interconversion of one enantiomer into its mirror-image in solution allows the 
resolution yield to surpass 50%. Nevertheless, CIET is of limited practical 
application, since approximately 90% of all chiral systems crystallize as racemic 
compounds.3  
Crystallization-induced diastereoisomer transformation (CIDT), in its turn, is 
analogous to classic resolutions which rely on solubility differences of 
diastereoisomeric intermediates. An optically pure resolving agent is used to 
generate diastereoisomers from a racemic mixture. Being a dynamic resolution, 
however, the epimerization of the diastereoisomers allow their interconversion 
in solution. As the less soluble diastereoisomer precipitates, the soluble fraction 
of the more soluble one is continuously converted into its epimer.4 This is the 
driving force that ultimately leads to a progressive diastereoisomeric enrichment 
of the precipitate (Figure 4).2 The last step is the recovery of the desired 
enantiomer from its diastereoisomer derivative.          
 
Figure 4. Asymmetric resolution; A: racemate; B: resolving agent 
There are three main criteria that should be considered in the development of a 
CIDT method: establishing conditions that enable epimerization; finding a 
suitable resolving agent that is effective and stable under the epimerization 
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conditions; isolating and handling the product under conditions that prevent 
degradation.5 The equilibration mechanisms include rotation around hindered 
bonds or formation and cleavage of activated bonds. It is worth noting, however, 
that many discoveries of CIDT processes remain fortuitous.3  
Thorough reviews on CIDT and mechanisms of epimerization have been 
conducted.3,5 Early examples often include the use of alkaloids as resolving 
agents. For instance, racemic indanone was successfully resolved into its (+)-
enantiomer with brucine in 93% yield (Figure 5). In this case, the keto/enol 
interconversion is the underlying mechanism that leads to epimerization. There 
are many other examples in which the relative acidity of a carbon-hydrogen 
bond plays a role in CIDT.3 
 
Figure 5. CIDT of indanone 
1.3 The Betti base 
The Betti base is an aminobenzylnaphthol, product of the a three-component 
condensation: β-naphthol, aryl aldehydes and ammonia. It is named after Mario 
Betti (1875-1942), who was responsible for its synthesis and early investigation 
of its properties, including as a resolving agent in asymmetric chemistry.4,6 
The field of research concerning the use of the Betti base and its derivatives 
has been intensified in the last decade. Several applications have been 
reported, including, for instance, stereoselective reaction of organometallic 
reagents, preparation of B-chiral boronate complexes, separation of 
enantiomers and as an organocatalyst.6 The straight forward synthesis and 
resolution of the Betti base along with its high reactivity makes it an interesting 
compound in the field of asymmetric organic chemistry.7  
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Figure 6. Betti base 
Tartaric acid is often used to resolve the Betti base into its enantiomers. In a 
successful attempt to further improve the chemical and optical yield of the 
procedures which had been reported, Hu and co-workers established an 
efficient resolution of racemic Betti base, which relies on enantioselective N,O-
deketalization of the racemic ketal in acetone solution.7 
L-(+)-tartaric acid initially promotes an acid-catalyzed N,O-ketalization of the 
Betti base, leading to the formation of the racemic ketal. Then, as a chiral acidic 
reagent, it selectively leads to the N,O-deketalization of the (S)-Betti base 
enantiomer. Subsequently, the L-(+)-tartaric acid selectively captures the (S)-
Betti base, precipitating it in its salt form. 7  
The (R)-Betti base, in its turn, is recovered from the filtrate as a N,O-ketal. 
Analogously, the use of D-(-)-tartaric acid allows the (R)-Betti base tartrate salt 
to be obtained from the ketal. Finally, both enantiomers may be obtained in high 
yield and enantiomeric excess from their respective tartrate salts, through 
neutralization and extraction.7       
Scheme 1. Hu’s kinetic resolution of the Betti base  
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1.4 Importance of amines in asymmetric organic chemistry 
Amines are widely employed in the previously described methods for resolution 
of racemic mixtures or synthesis of enantiomerically enriched compounds. A 
well-known enantioselective synthesis by List and co-workers employing the 
amino acid proline as a chiral catalyst is an example of asymmetric aldol 
reaction.8 Aminocatalysis is a whole field of study devoted to the application of 
amines as catalysts and to the investigation of the underlying mechanisms. 
Additionally, amines are often employed as resolving agents for acidic 
compounds, like in the previously mentioned example of indanone.3     
 
Figure 7. Asymmetric aldol reaction. 
Enantiomerically enriched amines are equally useful in asymmetric synthesis as 
building blocks for more complex molecules. Souers and co-workers studied the 
affinity between 2-amino-8-alcoxy quinolines and melanine-concentrating 
hormone (MCH) receptors, envisaging their application as MCH antagonists. By 
synthetizing several structural analogs from three moieties and assessing their 
affinity to the MCH receptor, a pair of enantiomers was shown to have a 20-fold 
difference in binding.9    
 
Figure 8. MCHr1 antagonist 
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2 Research Project 
2.1 Acid promoted CIDT deracemization of dihydrocinnamic aldehydes 
The research group in which the present work was developed has recently 
established a procedure for the deracemization of α-alkylated, α-epimerizable 
aldehydes of industrial interest, notably in perfumery, using 1-(aminobenzyl)-2-
naphthol (Betti base) as a resolving agent.4 This project was preceded by the 
work of Košmrlj and Weigel, who demonstrated that that (±)-2-ethylhexanal can 
be successfully converted into (R)-2-ethylhexanal (94% yield, er = 99 : 1) by 
CIDT with diastereoisomeric imines obtained with trans-(1R,2R)-6-nitro-1-
aminoindan-2-ol.10 
The condensation between the Betti base and aldehydes leads to the formation 
of 1,3-naphthoxazines which are subjected to an imine/enamine equilibrium. 
When a racemic α-alkylated aldehyde and a single Betti base enantiomer react, 
the resulting oxazine presents three stereogenic centers, one of which is 
defined.4 Fülöp and co-workers studied the tautomeric equilibrium of the 
condensation products between Betti base derivatives and aromatic aldehydes. 
Through NOESY spectra, it was unequivocally shown that the trans-disposed 
configuration of the 2,6-diaryl substituents in the perhydro-1,3-oxazine ring is 
favored.11  
   
Figure 9. Tautomeric equilibrium of 2,6-diaryl-perhydro-1,3-oxazines 
For this reason, two out of the three stereogenic centers of the condensation 
product between α-alkylated aldehydes and a single Betti base enantiomer may 
be considered as defined, for practical purposes. Therefore, the resulting 
equilibrium can be represented by two epimeric naphthoxazines, their 
corresponding imines and a common enamine intermediate (Figure 10).  
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Figure 10. Imine/enamine equilibrium of naphthoxazines derived from Betti base and α-alkylated 
aldehydes  
By applying experimental conditions which simultaneously allowed the 
interconversion of diastereoisomers and the preferential precipitation of one of 
them, and by using the Betti base as a resolving agent, racemic mixtures of five 
different dihydrocinnamic aldehydes were successfully resolved into their 
enantiomers. The procedure was so efficient that even when an indepently 
prepared diastereoisomerically enriched sample of the more soluble 
naphthoxazine (dr = 97.8 : 2.2) was employed, the less soluble naphthoxazine 
could be isolated by filtration in 95% yield and dr = 93 : 7, after 32 hours.4    
The reactions were initially carried out with racemic aldehydes in methanol, 
leading to the precipitation of nearly quantitative 1:1 mixtures of the resulting 
diastereoisomers. The suspension of the mixtures in refluxing methanol did not 
have any impact on the diastereoisomeric ratio. Nevertheless, when the 
mixtures were suspended in 2.5% acetic acid in methanol and heated to 65ºC, 
a progressive enrichment of the less soluble diastereoisomer was observed 
(Figure 11). Through acid promoted CIDT, diastereoisomeric ratios of up to 97:3 
were reached and the products were isolated by simple filtration. Finally, the 
enriched enantiomers and the resolving agent were recovered through the 
hydrolysis of naphthoxazinic derivatives. Final enantiomeric ratios of up to 96:4 
were obtained.4 
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Figure 11. Acid promoted CIDT of Helional® with (S)-Betti base  
2.2 Amine building blocks  
Based on the protocol for deracemization of dihydrocinnamic aldehydes4 and by 
analyzing other potentially useful molecules that could be obtained from the 
diastereisomerically enriched naphthoxazines, an alternative synthetic pathway 
was contemplated.  
A structural search (SciFinder®) of a 2-alkyl-3-aryl-propan-1-amine moiety 
(Figure 12) was carried out and returned over 6000 substances. Over 2000 
were related to biological applications, among which anti-tumoral, anti-infective 
and central nervous system related studies stood out. Envisaging the 
application of amines as possibly useful building blocks for biologically active 
compounds and considering the possibility of control over the stereochemistry 
of the 2-alkyl position, a synthetic route for enantiomerically enriched 2-alkyl-3-
aryl-propan-1-amines was proposed (Scheme 2).     
 
Figure 12. Structural search moiety 
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The procedure was equally based on crystallization-induced diastereoisomeric 
transformation of trans 2,6-disubstituted 1,3-naphthoxazines 3. Nevertheless, 
by modifying the subsequent reactions to the CIDT, 2-methyl-3-arylpropan-1-
amines ((S)-6, (R)-6, (S)-25) and their N-methyl derivatives ((S)-9, (R)-9, (S)-
28a) were obtained, rather than the dihydrocinnamic aldehydes (Table 1).     
 
Scheme 2. Synthetic pathway with Helional® and (R)-Betti base. 
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The Betti base, which was employed as a resolving agent in the previously 
described procedure4, was equally necessary for deracemization. However, it 
was essentially used as a reactant, considering that its nitrogen atom was 
retained in the structure of the final product. 
Table 1. Dihydrocinnamic aldehydes and corresponding final products   
Betti base 
enantiomer 
Dihydrocinnamic 
aldehyde 
2-alkyl-3-aryl-propan-1-amines N-methyl derivatives 
(R) 
 
rac-2 
 
(S)-6a 
 
(S)-9a 
(S)  
(R)-6a 
 
(R)-9a 
(S) 
 
rac-22 
 
(S)-25a 
 
(S)-28a 
 
Crystallization allowed further increase of the diastereoisomeric ratio after the 
CIDT. The fact that the naphthoxazinic diastereoisomers present significantly 
different solubilities in methanol4 was an indication that they could present 
similar behavior in different solvents. Therefore, crystallization assays were 
carried out and a suitable solvent was selected for each diastereoisomeric 
mixture (3 and 23).  
The amines were obtained from two consecutive hydrogenolysis of the 
diastereoisomerically enriched naphthoxazines (3 and 23). Fülop and coworkers 
have synthetized several Betti base derivates and explored their potentiality as 
chiral ligands in asymmetric chemistry.12,13 In some synthetic routes, the authors 
reported the use of hydrides, either NaBH4 and LiAlH4, in the reduction of the 
oxazinic C-O bond. Therefore, LiAlH4 was employed on the first hydrogenolysis 
step. The diastereoisomeric ratio of the resulting products (4 and 24) was 
likewise increased by crystallization.      
Catalytic hydrogen transfer (CHT) was then used to reduce the C-N bond and 
consequently release the enantiomerically enriched amines (6, 25) and 1-
benzylnaphthalen-2-ol 5 as a byproduct. This step, in its turn, transcends the 
context in which the Betti base is generally reported, despite the number of 
applications to which it has been associated.  
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The core moiety of the Betti base (aminobenzylnaphtol) is most often preserved 
throughout the synthetic routes discussed in related studies. When used as a 
chiral catalyst or resolving agent, for instance, it should in theory be 
recoverable. And when used as a reactant in asymmetric synthesis, the desired 
products are usually derivatives of the prototypical Betti base with applications 
in various fields. No references were found in which the N-C bond of a Betti 
base derivative was reduced to yield enantiomerically enriched compounds.  
The hydrogenolysis of N-C bond is often employed in deprotection N-benzyl 
protected amines. Ammonium formate was used as hydrogen donor and 10% 
palladium on carbon as catalyst.14 The reaction products were converted into 
hydrochloride salts to be recoverable by filtration and rendered more stable for 
storage. 
The reduction of both the C-O and C-N oxazinic bonds within a single step was 
not attempted, since the initial hydrogenolysis with LiAlH4 yields 
diastereoisomeric mixtures which could be enriched by crystallization.       
Through the reaction with Di-tert-butyl dicarbonate, a fraction of the product was 
N-protected. This procedure served two purposes. The first was to allow the 
determination of the enantiomeric ratio of the N-Boc derivatives 7 through chiral 
HPLC. The amine itself presented technical constraints which hampered its 
direct chromatographic analysis. 
The second was to allow monomethylation of the amines with methyl iodine. If 
an unprotected amine was used, dimethylation was most likely to occur. After 
alkylation, deprotection of the amine was carried out with trifluoroacetic acid, 
yielding the monomethylated amines 9a and (S)-25a, which were likewise 
converted into hydrochloride salts.  
Parallel syntheses with non-enriched mixtures of the epimeric naphthoxazines 
were conducted in order to allow the determination of suitable chromatographic 
parameters. This was accomplished simply by skipping the CIDT stage.    
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2.3 Synthetic application to real world target 
As an attempt to assess the usefulness of the amines as building blocks, the 
(S)-enantiomer of (2S,6R)-4-((*)-3-(4-(tert-butyl)phenyl)-2-methylpropyl)-2,6-
dimethylmorpholine (fenpropimorph, cis-(S)-21) and its related diastereoisomer 
(2R,6R)-4-((S)-3-(4-(tert-butyl)phenyl)-2-methylpropyl)-2,6-dimethylmorpholine 
trans-(S)-21 were synthetized (Scheme 3).  
Fenpropimorph is a morpholine fungicide whose biological activity is attributed 
to the inhibition of ergosterol synthesis. It is the active ingredient of agricultural 
formulations for the control of disease in banana and cereal crops and it is 
extensively used worldwide.15 It does not present any current pharmacological 
use. Nevertheless, the mechanism through which it operates is 
pharmacologically related to that of azole antifungals, which are widely 
employed as sterol biosynthesis inhibitors in the treatment of fungal infections. 
More importantly, fenpropimorph is structurally related to amorolfine 30, the 
active substance in nail lacquer formulations used in the treatment of mild 
fungal infections. 
 
Figure 13. Morpholine fungicides 
Even though the cis-(S)-enantiomer is known to present a higher biological 
acitivity, fenpropimorph is still marketed as a racemic mixture of the cis 
isomer.15 Nevertheless, enantioselective synthetic routes have been reported, 
either employing biocatalysis16 or asymmetric induction17.  
Considering the structure of the 2-alkyl-3-aryl-propan-1-amines, an alternative 
synthetic route for fenpropimorph was envisaged (Scheme 3). After protecting 
the hydroxyl group of lactic acid (S)-10 with dihydropyran, the carboxylic acid 
group was reduced. The resulting hydroxyl group was protected with benzyl 
chloride, followed by hydrolysis of the tetrahydropyranyl ether. Through 
nucleophilic substitution of racemic ethyl 2-bromopropanoate, a mixture of two 
diastereoisomers were formed 15.18,19 The ester group was then reduced and 
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the resulting products 16 were separated by chromatography. The benzyl 
ethers 17 were then deprotected through hydrogenolysis, followed by 
ditozylation. Finally, the diol leaving group was converted to iodide prior to the 
cyclization step.  
 
Scheme 3. Morpholine derivatives synthetic pathway. 
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3 Results and discussion 
3.1 Amine building blocks  
Table 2. Enantiomerically enriched amine building blocks 
Racemic aldehyde Betti base CIDT overall 
yield
a
; dr 
1
st
 hydrogenolysis 
overall yield
b
, dr 
Amine hydrochloride overall 
yield
c
; er 
 
rac-2 
(R) 
56.3%; 
97.6 : 2.4 
36.7%; 
98.6 : 1.4 
 
(S)-6b 
32.8%; 
97 : 3d 
 
rac-2 
(S) 
64.6%; 
97.2 : 2.8 
51.7%; 
98.4 : 1.6 
 
(R)-6b 
44.4% 
97.2: 2.8d 
 
rac-23 
(S) 
64.8%; 
94.4 : 5.6 
47.75%; 
96.4 : 3.7 
 
(S)-25b 
38.3%; 
97 : 3e 
a
Up to the first crystallization. 
b
Up to the second crystallization. 
c
Up to the recovery of the amine 
hydrochloride. 
d 
From N-Boc derivative of 6. 
e 
From N-Ts derivative of 28. 
 
The results show that the enantiomeric ratios of the 2-methyl-3-arylpropan-1-
amines indeed reflect the diastereoisomeric enrichment of their respective 
naphthoxazines. The products were obtained with a very straightforward 
procedure and in high enantiomeric ratios (er = 97 : 3). The initial two steps 
yield the naphthoxazine, which is a solid easily collected by filtration. The 
product of the first hydrogenolysis, in its turn, is simply obtained from the 
concentration of the filtrate followed by crystallization. Finally, the 
enantiomerically enriched 2-methyl-3-arylpropan-1-amines are obtained from 
the second hydrogenolysis and their conversion into hydrochloride salts allows 
them to be directly separated from the only major byproduct (1-
benzylnaphthalen-2-ol) by filtration. In summary, laborious work-up and 
purification steps are avoided throughout the procedure. 
It is worth noting that the synthesis and resolution of the Betti base is 
inexpensive and equally straightforward. Both its enantiomers can be recovered 
in high yields from the kinetic resolution with tartaric acid. 
The reaction yields up to the recovery of the amine hydrochloride can also be 
considered as satisfactory. If a classical resolution was employed, for instance, 
the resolution itself would limit the yield of a given enantiomer to 50%. 
 
20 
 
Considering the additional synthetic steps, the overall yield would probably be 
considerably lower. A 44.4% yield was obtained with the (R)-6b enantiomer. 
The difference to its enantiomer pair (S)-6b (32.8%) is merely circumstantial, 
since the synthetic pathway is reciprocal and chemically equivalent.   
The fraction of the product which is lost in the first crystallization step can be 
recycled. After all, it contains the epimeric naphthoxazines which can ungergo 
acid promoted CIDT. As previously mentioned, even diastereoisomerically 
mixtures that initially contain a higher concentration of the more soluble isomer 
are eventually converted into an enriched mixture of the less soluble one, when 
provided sufficient time during the acid promoted CIDT.4 Therefore, the loss 
generated by this step can be disregarded for practical purposes. The yield for 
the (R)-6b isomer, for instance, would reach 55%, surpassing the maximum 
theoretical threshold of a classical resolution. 
Table 3. Enantiomerically enriched N-methyl derivatives 
N-methyl hydrochloride derivative Yield
a
 Overall yield
b
 
 
(S)-9b 
59.1% 19.3% 
 
(R)-9b 
78.4% 34.4% 
 
(S)-28b 
59.8% 22.9% 
a From (S)-6b, (R)-6b and (S)-25b. b From racemic aldehyde     
3.2 Synthetic application do real world target 
Table 4. Morphiline derivatives 
Morpholine derivative Cyclization yield
a
 
 
fenpropimorph, cis-(S)-21 
82% 
 
trans-(S)-21 
90% 
a
 Section 5.3.9 
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The (S)-enantiomer of Fenpropimorph, to which its biological fungicide activity is 
mainly attributed, was successfully synthetized using the 2-alkyl-3-aryl-propan-
1-amine (S)-25b as an enantiomerically enriched building block. The NMR 
spectrum of the product was consistent with its structure and its molecular 
weight confirmed by mass spectrometry. 
Scaling-up costs were not yet evaluated. However, they should be considered 
in the future and confronted with the protocol established by Vinković and Šunjić 
through an asymmetric Mannich reaction (er = 97.6 : 2.4).17 The same research 
group had already accomplished enantioselective synthesis through 
biocatalysis and pointed out its scaling-up limitations.16,17 The use of the 
racemic mixture might be satisfactory for agricultural purposes. Nevertheless, if 
structurally related molecules eventually display therapeutic potential, the 
control over the stereochemistry might become particularly interesting. 
Some stages of the preparation of the 1-iodo-2-((1-iodopropan-2-yl)oxy)propane 
20 moieties initially presented some difficulties. The synthesis of ethyl 2-(((S)-1-
(benzyloxy)propan-2-yl)oxy)propanoate 15 (section 5.3.4) yielded some 
byproducts which were presumably the result of transesterification. 
Nevertheless, the addition of absolute ethanol and NaH led to the convergence 
of the reaction to 2-(((S)-1-(benzyloxy)propan-2-yl)oxy)propanoate 15 and ethyl 
2-ethoxypropanoate as main co-product, which was compatible with the 
hypothesis. And secondly, the final cyclization step was initially attempted with 
the ditosylated diol, but the yields were unsatisfactory. Therefore, the cyclization 
was preceded by a conversion of the leaving group into iodide. 
The stereochemistry of the final products was inferred from that of its two 
moieties: the enantiomerically enriched amine building block (S)-25a and the 1-
iodo-2-((1-iodopropan-2-yl)oxy)propane 20. One of the two stereocenters of 20 
is defined by the use of enantiomerically pure (S)-10 lactic acid. The 
stereochemistry of the second stereocenter, in its turn, is not so trivial. (S,R)-17 
and (S,S)-17 are diastereoisomers which  are obtained through 
chromatographic separation of isomeric mixture 16. After hydrogenolysis of the 
benzyl protecting group, two diols 18 are obtained, which are likewise 
diastereoisomers. The (R,S)-18, however, is a meso compound. Therefore, it 
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was possible to associate the elution profile of 17 to the corresponding 
diastereoisomer through the lack of optical activity of (R,S)-18.               
No discussions concerning the stereochemistry of amorolfine (30) or the 
implications on the biological properties were found. It is plausible to assume 
that its enantioselective synthesis could be accomplished with the same 
protocol, simply by using an aldehyde containing a tert-pentyl instead of a tert-
butyl substituent. However, the diastereoisomeric enrichment of the 
corresponding naphthoxazine should be attempted before any conclusions are 
drawn.  
No references were found concerning the trans-(S)-21 compound. Its NMR and 
MS spectra were equally compatible with its structure.  
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4 Conclusion 
The synthesis of enantiomerically enriched 2-alkyl-3-aryl-propan-1-amines was 
successfully accomplished. Given the high enantiomeric ratio achieved, these 
building blocks are potentially useful in the field of asymmetric organic 
chemistry, notably for pharmaceutically relevant compounds. A structural 
search reveled that these moieties, including specifically the ones which were 
obtained in this project, are present in numerous compounds of biological 
interest.  
As a preliminary attempt to assess the usefulness of the building blocks, 
fenpropimorph, a biologically active compound which contains the 2-alkyl-3-aryl-
propan-1-amine moiety, was synthetized in its enantiomerically enriched and 
most active form.       
This project is an example of how crystallization-induced diastereoisomer 
transformation (CIDT) can be useful in the field of asymmetric organic synthesis 
as a dynamic resolution method. Additionally, it provides a somewhat new 
perspective on the use of the Betti base. Even though the deracemization 
procedure was based on a previously reported resolution of dihydrocinnamic 
aldehydes, the hydrogenolysis of Betti base derived naphthoxazines as a 
source of enantiomerically enriched compounds had not yet been reported.        
As suggestions for future related projects, the search for biologically active 
compounds which contain the 2-alkyl-3-aryl-propan-1-amine moiety and in 
which the control over the stereochemistry of the 2-alkyl position is relevant 
could provide a starting point. Moreover, the synthesis of enantiomerically 
enriched amorolfine, a substance with known therapeutic properties, could be 
attempted, by applying the same protocol to the p-tert-pentyl substituted 
dihydrocinnamic aldehyde.  
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5 Experimental procedures 
NMR: 1H spectra were recorded at 400 and 600 MHz; 13C spectra were 
recorded at 75 and 100 MHz. Carbon multiplicity was assessed with DEPT. 
Solvent: CDCl3 (tetramethylsilane 0.03%), except when otherwise specified.          
HPLC: Hewlett Packard 1100; column and chromatographic parameters are 
specified in corresponding assays; diode array detector (DAD).  
Gas chromatography: Agilent 6850, Agilent HP1 column, 100% 
dimethylpolysiloxane 30 m x 0,32 mm, 0,25 µm; chromatographic parameters 
are specified in corresponding assays; flame ionization detector (FID).   
Mass spectrometry: Waters Micromass 4000, ESI-MS, solvent: MeOH, positive 
ion scan.     
Flash chromatography: stationary phase SiO2: Kieselgel Merck (230-400 Mesh, 
60 Å, Sigma-Aldrich).   
Melting point: Bibby Stuart Scientific SMP3. 
Specific rotation: Perkin Elmer 341 polarimeter.  
Vacuum distillation: Büchi GKR-50. 
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5.1 Synthesis of 3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropan-1-amine 6a 
and N-methyl derivative 9a. 
5.1.1 Synthesis of 3-(1-(benzo[d][1,3]dioxol-5-yl)propan-2-yl)-1-phenyl-2,3-
dihydro-1H-naphtho[1,2-e][1,3]oxazine (1R, 3S)-3 and (1S, 3R)-3.4 
 
(R)-1 (3.74 g, 15 mmol) was suspended in methanol (75 mL) at room 
temperature. rac-2 (3.03g, 15.75mmol) was added and the suspension was left 
under stirring for two hours. (1R,3S)-3 was collected by filtration as a white 
solid, washed with methanol and dried under reduced pressure (6.04 g). Yield: 
95%; dr = 50 : 50. NMR spectra were compatible with those reported in 
literature.4 
 
The same protocol was applied in the synthesis of (1S,3R)-3. The (S)-1 Betti 
base was instead used. Yield: 95%. NMR spectra were compatible with those 
reported in literature.4         
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5.1.2 CIDT of 3-(1-(benzo[d][1,3]dioxol-5-yl)propan-2-yl)-1-phenyl-2,3-dihydro-
1H-naphtho[1,2-e][1,3]oxazine 3. 
 
The approximately 1:1 mixture of the (1R,3S,R)-3 and (1R,3S,S)-3 isomers 
(5.94 g, 14 mmol) was suspended in a 2.5% acetic acid solution in methanol 
(140 mL). After 48 hours under stirring at 60ºC, the solid was collected by 
filtration, washed with methanol and dried under reduced pressure. Yield: 4.52g, 
76%; dr = 95.8 : 4.2.  
The solid (4.50g) was crystallized in toluene (10 mL/g). After filtration and 
drying, (1R,3S,S)-3 was recovered. Yield: 3.52g, 78%; dr = 97.6 : 2.4. NMR 
spectra were compatible with those reported in literature.4 
 
The same protocol was applied in the CIDT of (1S,3R)-3, which yields the 
(1S,3R,R)-3 enriched mixture. Yield: 85%; yield (crystallization): 80%. dr = 97.2 
: 2.8. NMR spectra were compatible with those reported in literature.4  
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5.1.3 Synthesis of 1-(((3-(benzo[d][1,3]dioxol-5-yl)-2-
methylpropyl)amino)(phenyl)methyl)naphthalen-2-ol (1R,S)-4 and (1S,R)-4.    
 
(1R,3S,S)-3 (2.06 g, 4.87 mmol) was dissolved in anhydrous THF (28mL). This 
solution was added dropwise to a cooled suspension of LiAlH4 (0.23 g, 6.1 
mmol) in anhydrous THF (6mL), maintaining the temperature under 20ºC. The 
suspension was then heated to reflux and the reaction was monitored by TLC. 
After an hour, the suspension was cooled the reaction slowly quenched with a 
saturated aqueous NH4Cl solution (3 mL) and left under stirring for two hours. 
The suspension was filtered and the solid consecutively washed with CH2CH2 
and THF. The filtrate fractions were concentrated dried under reduced pressure 
(2.05 g). Yield = 79.3%.  
The solid (2.05 g) was then heated in 60mL of isopropyl alcohol until complete 
dissolution, left at ambient pressure for several hours and finally cooled with an 
ice bath. After filtration and drying, (1R,S)-4 was recovered. Yield: 1.70g, 82%; 
mp = 121-122 ºC; dr = 98.6 : 1.4; [α]D
22 = -122.2 (c 1.06, CHCl3). 
1H NMR 600 MHz (CDCl3): δ ppm 13.60 (bs, 1H), 7.77-7.67 (m, 3H), 7.41-7.37 
(m, 2H), 7.32 (m, 1H), 7.26 (m, 2H), 7.23-7.19 (m, 2H), 7.15 (d, J = 8.8 Hz, 1H), 
6.66 (d, J = 8.8 Hz, 1H), 6.60 (d, J = 1.5 Hz, 1H), 6.54 (dd, J = 7.9 and 1.6 Hz, 
1H), 5.86 (dd, J = 7.9 and 1.4 Hz, 2H), 5.57 (s, 1H), 2.77 (dd, J = 11.8 and 5.6 
Hz, 1H), 2.64 (m, 1H), 2.50 (dd, J = 13.8 and 6.7 Hz, 1H), 2.38 (dd, J = 13.8 
and 7.6 Hz, 1H), 1.79 (m, 1H), 1.61 (bs, 1H), 0.96 (d, J = 6.7 Hz, 3H). 
Diagnostic signal (dr): δ ppm 5.57.  
13C NMR 150 MHz (CDCl3): δ ppm 156.6, 147.5, 145.8, 141.5, 133.8, 132.6, 
129.6, 129.0, 128.8, 128.6, 128.0, 127.6, 126.4, 122.3, 121.8, 121.1, 120.0, 
113.3, 109.2, 108.1, 100.7, 64.3, 55.3, 41.5, 33.4, 18.3. 
Using the same protocol, the (1S,3R,R)-3 enriched mixture was used in the 
synthesis of the corresponding enantiomer (1S,R)-4. Yield (overall): 80%; mp = 
122-123 ºC; dr = 98.4 : 1.6;  [α]D
19 = -101.0 (c 1.2, CHCl3). The NMR estimated 
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diastereoisomeric ratio was confirmed by chromatography with the N-Boc/O-
Boc derivative of (1S, R)-4, HPLC Chiralcel® AD-H, hexane/i-PrOH 95:5, 1 
mL/min, 230 nm, trmin = 6.56, trmaj = 7.69. 
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5.1.4 Synthesis of 3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropan-1-aminium 
chloride (S)-6b and (R)-6b.  
 
(1R,S)-4 (2.13 mg, 5.0 mmol) was added to methanol (250 mL) and heated  to 
reflux temperature (65 ºC) until complete dissolution. 10% palladium on carbon 
(426 mg) and HCO2NH4 (1.10 g, 17.5 mmol) were consecutively added to the 
solution. The suspension was kept at reflux and the reaction was monitored by 
TLC. After 16 hours, the catalyst was separated by filtration with Celite®. The 
filtrate was concentrated and the crude product was dissolved in anhydrous 
Et2O (8mL).  
The solution was cooled with an ice bath and HCl 2M in Et2O was slowly added 
(5 mL), under nitrogen and stirring. After two hours, the hydrochloride salt was 
collected by filtration, washed with anhydrous Et2O and dried under reduced 
pressure. Yield: 1.03 g, 89.7%; crystallized from i-PrOH, mp = 179-181 ºC; 
[α]D
21 = +1.3 (c 1.55, MeOH). In order to recover the byproduct 5, the filtrate 
was neutralized with NaHCO3 solution, dried with Na2SO4 and concentrated.
 Its 
NMR spectrum was compatible with the literature.20 
1H NMR 600 MHz (CD3OD): δ ppm 6.73 (d, J = 7.8 Hz, 1H), 6.71 (s, 1H), 6.65 
(d, J = 7.8 Hz, 1H), 5.89 (s, 2H), 2.91 (dd, J = 12.6 and 5.3 Hz, 1H) , 2.74 (dd, J 
= 12.6 and 8.3 Hz, 1H), 2.65 (dd, J = 13.7 and 6.3 Hz, 1H), 2.41 (dd, J = 13.7 
and 8.3 Hz, 1H), 2.06 (m, 1H), 0.97 (d, J = 6.8 Hz, 3H).    
13C NMR 150 MHz (CD3OD): δ ppm 147.8, 146.2, 132.8, 121.8, 108.9, 107.7, 
100.8, 44.6, 39.7, 33.7, 15.8.   
 
The same protocol was applied with (1S,R)-4 in the synthesis of the 
corresponding enantiomer (R)-6b. Yield: 86%, crystallized from i-PrOH mp = 
180-181 ºC; [α]D
21 = -1.1 (c 1.3, MeOH). 
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5.1.5 Synthesis of tert-butyl (3-(benzo[d][1,3]dioxol-5-yl)-2-
methylpropyl)carbamate (S)-7 and (R)-7.   
 
NaOH 2M aq. (1.65 mL, 3.3 mmol) was added dropwise to a suspension of (S)-
6b (344 mg, 1.5 mmol) in t-BuOH (1.1 mL). After dissolution, a solution of di-
tert-butyl dicarbonate (334 mg, 1.53 mmol) in t-BuOH (0.5 mL) was added 
dropwise and under stirring to the previous solution along one hour. The 
reaction was monitored by TLC. After 6 hours, the aqueous phase was 
separated with 15 mL of Et2O in a separating funnel. The organic phase was 
dried with NaSO4, the product purified by flash chromatography (5-10% EtOAc 
in petroleum ether) and dried under reduced pressure. Yield: 433 mg, 98.4%; 
HPLC Phenomenex Lux Amylose-2, hex/i-PrOH 90:10, 1 mL/min, 230 nm, trmaj 
= 10.91 min, trmin = 9.19, er = 97 : 3; [α]D
18 = +10.8 (c 1.48, CHCl3). 
1H NMR 600 MHz (CD3OD): δ ppm 6.72 (d, J = 7.8 Hz, 1H), 6.64 Hz (s, 1H), 
6.59 Hz (d, J = 7.8 Hz, 1H), 5.91 (s, 2H), 4.56 (bs, 1H), 3.09 (m, 1H), 2.97 (m, 
1H), 2.60 (dd, J = 13.7 and 5.9 Hz, 1H), 2.30 (dd, J = 13.7 and 8.4 Hz, 1H), 2.85 
(m, 1H), 1.44 (s, 9H), 0.86 (d, J = 6.8 Hz, 3H).  
13C NMR 150 MHz (CD3OD): δ ppm 156.0, 147.5, 145.7, 134.2, 121.8, 109.3, 
108.0, 100.7, 79.0, 46.2, 40.6, 35.9, 28.4, 17.3.   
 
The same protocol was applied with (R)-6b in the synthesis of the 
corresponding enantiomer (R)-7. Yield: 93%; HPLC Phenomenex Lux Amylose-
2, hexane/i-PrOH 90:10, 1 mL/min, 230 nm, trmaj = 9.19 min, trmin = 10.9 min, er 
= 97.2 : 2.8; [α]D
20 = -9.4 (c 0.84, CHCl3).    
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5.1.6 Synthesis of tert-butyl (S)-(3-(benzo[d][1,3]dioxol-5-yl)-2-
methylpropyl)(methyl)carbamate (S)-8.     
 
60% NaH in mineral oil (71 mg, 1.78 mmol) was added to a solution of (S)-7 
(433 mg, 1.48 mmol) in THF cooled with an ice bath. Methyl iodine was then 
added (0.14 mL, 2.29 mmol). After three hours under stirring, a TLC (5% EtOAc 
in petroleum ether) showed no evidence of the product. The reaction was then 
left at room temperature for another three hours, after which the reaction was 
apparently complete. Saturated aqueous NH4Cl was used to quench it. The 
organic phase was concentrated and the aqueous phase washed with Et2O, 
which was used to redissolve the product. This solution was then washed with 
brine-H2O 1:1 to neutrality, dried with Na2SO4 and concentrated. The product 
was purified by flash chromatography. Yield: 353 mg, 77%; [α]D
23 = +2.7 (c 1.9, 
CHCl3). 
1H NMR 400 MHz (CDCl3) temp = 50 ºC: δ ppm 6.71 (d, J = 7.8 Hz, 1H), 6.63 
(d, J = 1.4 Hz, 1H), 6.58 (dd, J = 7.8 and 1.4 Hz, 1H), 5.90 (s, 2H), 3.15 (dd, J = 
13.7 Hz and 6.8 Hz, 1H), 3.08 (bs, 1H), 2.83 (bs, 3H), 2.58 (dd, J = 13.7 and 5.5 
Hz, 1H), 2.25 (dd, J = 13.7 and 8.6 Hz, 1H), 2.00 (m, 1H), 1.45 (s, 9H), 0.83 (d, 
J = 6.6 Hz, 3H). 
 
The same protocol was applied with (R)-7 in the synthesis of the corresponding 
enantiomer (R)-8. Yield: 98%, [α]D
21 = -0.46 (c 3.0, CHCl3).  
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5.1.7 Synthesis of (S)-3-(benzo[d][1,3]dioxol-5-yl)-N,2-dimethylpropan-1-amine 
hydrochloride (S)-9b.     
 
(S)-8 (352 mg, 1.14 mmol) was added to a solution of CF3CO2H (1 mL) and 
CH2Cl2 (1 mL), which was left under stirring for one hour and then concentrated. 
Saturated aqueous NaHCO3 (3 mL) was added to the residue under stirring. A 
progressive color change was observed, which ceased after two hours. THF (2 
mL) was then added. The product was extracted with CHCl3 (3 x 4 mL) and the 
organic phase washed with brine-H2O 1:1 (2 x 2 mL), brine (1 mL) and dried 
with Na2SO4.  
HCl 2M in Et2O (1.5 mL) was added to a solution of the product in anhydrous 
Et2O (3 mL), which was kept under stirring for one hour. The resulting 
suspension was filtrated. The solid was washed with anhydrous Et2O and dried 
under reduced pressure. Yield: 219 mg, 78.8%; crystallized from CH3CN mp = 
147-149 ºC; [α]D
22 = +8.2 (c 1.55, MeOH). 
1H NMR 600 MHz (CD3CN): δ ppm 8.97 (bs, 2H), 6.78 (bs, 1H), 6.74 (d, J = 7.9 
Hz, 1H), 6.67 (d, J = 7.9 Hz, 1H), 5.93 (m, 2H), 2.88-2.79 (m, 1H), 2.79-2.69 (m, 
2H), 2.55 (bs, 3H), 2.37 (m, 1H), 2.23 (m, 1H), 0.96 (d, J = 6.2 Hz, 3H). 
13C NMR 150 MHz (CD3CN): δ ppm 149.1, 147.4, 134.8, 123.6, 110.8, 109.3, 
102.5, 55.9, 41.2, 34.6, 34.1, 18.2. 
 
The same protocol was applied with (S)-8 in the synthesis of the corresponding 
enantiomer (S)-9b. Yield: 86%; crystallized from CH3CN mp = 145-148 ºC; 
[α]D
20 = -1.8 (c 1.4, MeOH).  
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5.2 Synthesis of (S)-3-(4-(tert-butyl)phenyl)-2-methylpropan-1-amine (S)-
25a and N-methyl derivative (S)-28a. 
5.2.1 Synthesis of (1S,3R)-3-(1-(4-(tert-butyl)phenyl)propan-2-yl)-1-phenyl-2,3-
dihydro-1H-naphtho[1,2-e][1,3]oxazine (1S,3R)-23.  
 
(S)-1 (2.49g, 10 mmol) was suspended in methanol (50 mL) at room 
temperature. rac-23 (2.14 g, 10.1 mmol) was added and the suspension was 
left under stirring for two hours. (1S,3R)-23 was collected by filtration as a white 
solid, washed with methanol and dried under reduced pressure. Yield: 3.9 g, 
90%; dr = 50 : 50.4  
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5.2.2 CIDT of (1S,3R)-23 followed by crystallization in cyclohexane. 
 
The approximately 1:1 mixture of (1S,3R,S) and (1S,3R,R) isomers (4.35g, 10 
mmol) was suspended in a 10% acetic acid solution in methanol (30 mL). After 
60 hours under stirring at 60ºC, the solid was collected by filtration, washed with 
methanol and dried under reduced pressure. Yield: 4.17g, 96%; dr = 90 : 10.4  
The solid (4.10g) was crystallized in cyclohexane (105 mL). After filtration and 
drying, (1S,3R,S)-23 was recovered. Yield: 3.07g, 75%; dr = 94.4 : 5.6.4 
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5.2.3 Synthesis of 1-((S)-(((S)-3-(4-(tert-butyl)phenyl)-2-
methylpropyl)amino)(phenyl)methyl)naphthalen-2-ol (1S,S)-24 followed by 
crystallization in n-hexane. 
  
(1S,3R)-23 (5.05g, 11,59 mmol) was dissolved in anhydrous THF (70 mL). This 
solution was added dropwise to a cooled suspension of LiAlH4 (0.56 g, 14.8 
mmol) in anhydrous THF (10 mL), maintaining the temperature under 20ºC. The 
suspension was then heated to reflux temperature (66 ºC) and the reaction was 
monitored by TLC (5% EtOAc in petroleum ether). After three hours, the 
suspension was cooled with an ice bath. The reaction was slowly quenched 
with a saturated aqueous NH4Cl solution (7.5 mL) and left under stirring for two 
hours. The organic phase was separated and filtered. The remaining solid was 
consecutively washed with THF (20 mL) and CH2CH2 (20 mL). The organic 
phases were then concentrated. The resulting solid was redissolved in 70 mL of 
CH2Cl2 and consecutively washed with water (2 x 10 mL) and brine (10 mL). 
The solution was finally dried with Na2SO4, concentrated and dried under 
reduced pressure. Yield = 4.27g, 84%.     
The solid (4.27g) was crystallized in n-hexane (45 mL). After filtration and 
drying, (1S,S)-24  was recovered. Yield: 3.34g, 78% overall; dr = 96.3 : 3.7. 
1H NMR 600 MHz (CDCl3): δ ppm 13.60 (bs, 1H), 7.73-7.67 (m, 3H), 7.43 (m, 
2H), 7.35-7.19 (m, 7H), 7.16 (d, J = 8.7 Hz, 1H), 7.05 (m, 2H), 5.62 (s, 1H), 2.81 
(bs, 1H), 2.71 (dd, J = 13.8 and 5.8 Hz, 1H), 2.67 (dd, J = 11.8 and 6.6 Hz, 1H), 
2.39 (dd, J = 13.8 and 8.7 Hz, 1H), 2.07 (m, 1H), 1.96 (bs, 1H), 1.28 (s, 9H), 
0.91 (d, J = 6.7 Hz, 3H). Diagnostic signal (dr): δ ppm 5.62. 
13C NMR 150 MHz (CDCl3): δ ppm 156.7, 148.8, 141.6, 136.9, 132.6, 129.6, 
129.1, 128.8, 128.64, 128.60, 128.1, 127.7, 126.4, 125.2, 122.3, 121.1, 120.1, 
113.5, 64.4, 55.2, 40.6, 34.7, 34.7, 31.4, 17.9.  
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5.2.4 Synthesis of (S)-3-(4-(tert-butyl)phenyl)-2-methylpropan-1-amine 
hydrochloride (S)-25b.  
 
(1S,S)-24 (1.95 mg, 4.44 mmol) was added to methanol (80 mL) and heated  to 
reflux temperature (65 ºC) until complete dissolution. 10% palladium on carbon 
(195 mg) and HCO2NH4 (1.12 g, 17.8 mmol) were consecutively added to the 
solution. The suspension was kept at reflux and the reaction was monitored by 
TLC. After 24 hours, the catalyst was separated by filtration with Celite®. The 
filtrate was concentrated and the crude product was dissolved in anhydrous 
CH2Cl2. This solution was dried with Na2SO4 and concentrated.  
The crude product was then redissolved in anhydrous Et2O (4.4 mL) and the 
solution was cooled with an ice bath. HCl 2M in Et2O was slowly added (2.5 mL) 
under nitrogen and stirring. After 40 minutes, the hydrochloride salt was 
collected by filtration, washed with anhydrous Et2O and dried under reduced 
pressure. Yield: 865 mg, 80.6%; crystallized from i-PrOH mp = 162-164 ºC; 
[α]D
21 = +1.6 (c 1.00, MeOH). 
1H NMR 600 MHz (CD3OD): δ ppm 7.33 (m, 2H), 7.14 (m, 2H), 2.93 (dd, J = 
12.6 and 5.5 Hz, 1H), 2.76 (dd, J = 12.6 and 8.4 Hz, 1H), 2.71 (dd, J = 13.4 and 
6.5 Hz, 1H), 2.48 (dd, 13.4 and 8.2 Hz, 1H), 2.11 (m, 1H), 1.30 (s, 9H), 0.99 (d, 
J = 6.7 Hz, 3H).   
13C NMR 150 MHz (CD3OD): δ ppm 151.2, 138.2, 130.7, 127.2, 46.9, 41.8, 
36.1, 35.8, 32.7, 18.1.   
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5.2.5 Synthesis of tert-butyl (S)-(3-(4-(tert-butyl)phenyl)-2-
methylpropyl)carbamate (S)-26.  
 
NaOH 2M aq. (2.20 mL, 3.3 mmol) was added dropwise to a suspension of (S)-
25b (482 mg, 2.0 mmol) in t-BuOH (1.1 mL). After dissolution, a solution of di-
tert-butyl dicarbonate (445 mg, 2.0 mmol) in t-BuOH (0.7 mL) was added 
dropwise and under stirring to the previous solution along one hour. The 
reaction was monitored by TLC (5% of (10% NH4OH aq. in methanol) in CH2Cl2; 
KMnO4 as visualization agent). After 6 hours, the aqueous phase was 
separated with 20 mL of Et2O in a separating funnel. The organic phase was 
dried with NaSO4, the product purified by flash chromatography and dried under 
reduced pressure. Yield: 515 mg, 84.7%; [α]D
26 = +10.1 (c 1.50, CHCl3). 
1H NMR 600 MHz (CDCl3): δ ppm 7.29 (m, 2H), 7.07 (m, 2H), 4.54 (bs, 1H), 
3.10 (m, 1H), 2.99 (m, 1H), 2.64 (dd, J = 13.7 and 6.0 Hz, 1H), 2.36 (dd, J = 
13.7 and 8.2 Hz, 1H), 1.91 (m, 1H), 1.44 (s, 9H), 1.30 (s, 9H), 0.88 (d, J = 6.8 
Hz, 3H).    
13C NMR 150 MHz (CDCl3):  δ ppm 156.1, 148.7, 137.2, 128.7, 125.1, 79.0, 
46.3, 40.4, 35.7, 34.3, 31.4, 28.4, 17.5. 
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5.2.6 Synthesis of tert-butyl (S)-(3-(4-(tert-butyl)phenyl)-2-
methylpropyl)(methyl)carbamate (S)-27. 
 
A solution of (S)-26 (504 mg, 1.65 mmol) in anhydrous THF (2 mL) was added 
to a suspension of 60% NaH in mineral oil (99 mg, 2.48 mmol) in anhydrous 
THF (0.5 mL) cooled with an ice bath. Methyl iodine was added (0.20 mL, 3.30 
mmol) under stirring and the reaction was monitored by tlc (5% EtOAc in 
petroleum ether). After 6 hours at room temperature, the reaction was 
apparently complete and saturated aqueous NH4Cl was used to quench it. The 
organic phase was concentrated and the aqueous phase washed with Et2O, 
which was used to redissolve the product. TLC showed the presence of the 
product in the aqueous phase, which was washed with CH2Cl2. The organic 
phases were then washed with brine-H2O 1:1 to neutrality, dried with Na2SO4 
and concentrated. The product was purified by flash chromatography. Yield: 
465 mg, 88.2%; [α]D
24 = +2.1 (c 1.06, CHCl3). 
1H NMR 600 MHz (CDCl3) temp = 50ºC: δ ppm 7.28 (m, 2H), 7.06 (m, 2H), 3.17 
(dd, J = 13.6 and 6.7 Hz, 1H), 3.08 (bs, 1H), 2.83 (bs, 3H), 2.63 (dd, J = 13.4 
and 5.1 Hz, 1H), 2.30 (dd, J = 13.6 and 8.8 Hz, 1H), 2.06 (m, 1H), 1.44 (s, 9H), 
1.30 (s, 9H), 0.84 (d, J = 6.7 Hz, 3H). 
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5.2.7 Synthesis of (S)-3-(4-(tert-butyl)phenyl)-N,2-dimethylpropan-1-amine 
hydrochloride (S)-28b. 
 
CF3CO2H (1 mL) was added to a solution (S)-27 (454 mg, 1.42 mmol) in 
CH2Cl2, which was left under stirring for 30 minutes and then concentrated. 
Et2O (4 mL) and saturated aqueous Na2CO3 (1 mL) were added to the residue. 
The organic phase was then separated, washed with brine (1 mL) and 
concentrated. The product was dried under reduced pressure. Yield: 300 mg, 
96.3%.    
HCl 2M in Et2O (1.5 mL) was added to a solution of the product in anhydrous 
Et2O (4 mL), which was kept under stirring for 30 minutes. The resulting 
suspension was filtrated. The solid was washed with anhydrous Et2O and dried 
under reduced pressure. Yield: 289 mg, 80.0%; crystallized from i-PrOH mp = 
219-222 ºC; [α]D
25 = +8.1 (c 1.23, CH3OH).  
1H NMR 600 MHz (CD3OD): δ ppm 7.34 (m, 2H), 7.12 (m, 2H), 2.95 (dd, J = 
12.5 and 5.3 Hz, 1H), 2.84 (dd, 12.5 and 8.7 Hz, 1H), 2.68 (s, 3H), 2.68 (dd, J = 
13.7 and 6.5 Hz, 1H), 1.48 (dd, 13.7 and 8.2 Hz, 1H), 2.13 (m, 1H), 1.29 (s, 9H), 
0.99 (d, 6.7 Hz, 3H).  
13C NMR 150 MHz (CD3OD): δ ppm 151.3, 138.0, 130.7, 127.3, 57.0, 41.8, 
36.1, 35.1, 35.0, 32.7, 18.2.  
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5.2.8 Synthesis of ((S)-N-(3-(4-(tert-butyl)phenyl)-2-methylpropyl)-N,4-
dimethylbenzenesulfonamide (S)-29. 
 
Pyridine (0,03 mL) and TsCl (36 mg, 0.19 mmol) were consecutively added to a 
solution of (S)-28a (27 mg, 0.124 mmol) in CH2Cl2 (0,2 mL), under nitrogen and 
stirring. After four hours at 0 ºC, the reaction was left at room temperature for 
another 20 hours. Et2O (10 mL) was added and the solution was washed with 
water (3 x 1 mL) and brine (1 mL) and dried with Na2SO4. The residue was 
purified by flash chromatography. Yield: 37.4 mg, 80%; [α]D
26 = +20.4 (c 1.67, 
CHCl3); HPLC Chiralcel
® OJ-H, n-hexane:i-PrOH 85:15, 1 mL/min, λ=220 nm, 
trmin = 38.58, trmaj = 45.43, er = 97 : 3.    
1H NMR 600 MHz (CDCl3): δ ppm 7.65 (m, 2H), 7.30 (m, 2H), 7.29 (m, 2H), 
7.07 (m, 2H), 2.86 (dd, J = 13.0 and 6.9 Hz, 1H), 2.81 (dd, J = 13.0 and 7.9 Hz, 
1H), 2.75 (dd, J = 13.7 and 5.3 Hz, 1H), 2.70 (s, 3H), 2.42 (s, 3H), 2.33 (dd, J = 
13.7 and 8.9 Hz, 1H), 2.01 (m, 1H), 1.31 (s, 9H), 0.92 (d, J = 6.7 Hz, 3H). 
13C NMR 150 MHz (CDCl3): δ ppm 148.7, 143.1, 137.1, 134.4, 129.6, 128.7, 
127.4, 125.1, 56.3, 40.1, 35.3, 34.3, 33.5, 31.4, 21.4, 17.3.     
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5.3 Synthesis of (2S,6R)-4-((S)-3-(4-(tert-butyl)phenyl)-2-methylpropyl)-2,6-
dimethylmorpholine cis-(S)-21 and (2S,6S)-4-((S)-3-(4-(tert-butyl)phenyl)-2-
methylpropyl)-2,6-dimethylmorpholine trans-(S)-21. 
5.3.1 Synthesis of (1S)-1-((tetrahydro-2H-pyran-2-yl)oxy)ethan-1-ol (S)-12. 
 
PSTA mohohydrate (2.4 mg) was added to a solution of ethyl (S)-2-
hydroxypropanoate 98% (2.06 g, 17 mmol) in CH2Cl2 (5 mL). The solution was 
cooled to 5ºC and DHP 97% (1.41 mL, 15 mmol) was added dropwise. The 
reaction was maintained for 5ºC for 15 minutes and then left at ambient 
temperature. It was monitored by TLC (25% EtOAc in hexane) and after five 
hours the starting material was apparently consumed. The mixture was diluted 
with Et2O (5 mL), quenched with saturated aqueous NaHCO3 (5 mL) and kept 
under vigorous stirring for 30 minutes. The aqueous phase was then separated. 
The organic phase was consecutively washed with water (2 x 3 mL) and brine 
(3 mL), dried with Na2SO4 and concentrated. Yield (crude product): 3.01 g. The 
NMR spectra were compatible with those reported in literature.17 
The crude product (3.00 g) was dissolved in anhydrous THF (80 mL) and added 
dropwise to a suspension of LiAlH4 in anhydrous THF (20 mL), maintaining the 
temperature at approximately 30 ºC. The mixture was left at ambient 
temperature for one hour and then at reflux for two hours. The suspension was 
filtered and the filtrate concentrated. The residue was dissolved in Et2O (50 
mL), washed with water (2 x 5 mL) and brine (5 mL), and dried with Na2SO4. 
The product was purified with flash chromatography. Yield (1,40 g, 87%, two 
stereoisomers with 63 : 37 ratio). 
13C NMR 100 MHz (CDCl3): Major isomer: δ ppm 99.0, 74.8, 66.1, 63.0, 31.0, 
25.3, 20.0, 17.6. Minor isomer: δ ppm 99.8, 77.6, 67.1, 64.4, 31.5, 25.0, 20.8, 
17.1.    
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5.3.2 Synthesis of 2-((S)-1-(benzyloxy)ethoxy)tetrahydro-2H-pyran (S)-13. 
 
A solution of (S)-12 (5.4 g, 33.7 mmol) in anhydrous THF (60 mL) was added 
dropwise to a suspension of NaH (1.57 g, 39.3 mmol) in THF (20 mL) cooled 
with an ice bath. The reaction was left ambient temperature for 30 minutes and 
once again cooled with an ice bath. Benzyl bromide 98% (1.46 mL, 35 mmol) 
was added dropwise. The reaction was then left at ambient temperature and 
monitored by TLC. After 24 hours, the product was purified by flash 
chromatography. Yield: 6.8 g, 80,7%. 
13C NMR 100 MHz (CDCl3). Major isomer: δ ppm 138.4, 128.3, 127.6, 127.5, 
98.9, 74.3, 73.2, 72.0, 62.7, 31.0, 25.5, 19.9, 18.7. Minor isomer: δ ppm 138.8, 
128.3, 127.5, 127.4, 96.2, 74.2, 73.2, 70.5, 62.2, 31.0, 25.5, 19.5, 16.5.        
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5.3.3 Synthesis of (S)-1-(benzyloxy)propan-2-ol (S)-14. 
 
HCl 6M in water (0,30 mL) was added to a solution of (S)-13 (2.25 g) in 
methanol (40 mL). The reaction was monitored by TLC and after 24 hours it 
was neutralized with a saturated aqueous solution of NaHCO3. The product was 
recovered with CH2Cl2 with a separating funnel. The organic phase was washed 
with water and brine and dried with Na2SO4. Purified by flash chromatrography 
and distilled Kugelrohr (105ºC/0.3 mm); yield (1.46 g, 98%); [α]D
23 = +15.2 (c 
1.59, CHCl3). 
1H NMR 400 MHz (CDCl3): δ ppm 7.28-7-16 (m, 5H), 4.45 (s, 2H), 3.89 (m, 1H), 
3.35 (dd, J = 9.5 and 3.3 Hz, 1H), 3.19 (dd, J = 9.5 and 7.9 Hz, 1H), 2.67 (bs, 
1H), 1.04 (dd, J = 6.4 Hz, 3H).   
13C NMR 100 MHz (CDCl3): δ ppm 137.9, 128.4, 127.8, 127.7, 75.8, 73.3, 66.5, 
18.6.   
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5.3.4 Synthesis of ethyl 2-(((S)-1-(benzyloxy)propan-2-yl)oxy)propanoate 15. 
 
A solution of (S)-14 (665 mg, 4 mmol) in anhydrous THF (1 mL) was added to a 
cooled suspension of NaH 60% in mineral oil (176 mg, 4.4 mmol) in anhydrous 
THF (4 mL) under stirring. The mixture was left at room temperature for 30 
minutes. A solution of racemic ethyl 2-bromopropanoate (1.58 mL, 12 mmol) in 
anhydrous THF was then added dropwise, along 45 minutes, maintaining the 
temperature at approximately 3ºC. The reaction was monitored by GC (initial 
temp = 60ºC, hold time1 = 2 min; ramp 10ºC/min to 270 ºC, hold time2 = 15 min; 
carrier gas H2;) and initial assays revealed the presence transesterification 
byproducts. For this reason, anhydrous EtOH (0,28 mL) and NaH (170 mg, 4,25 
mmol) were added, leading to the convergence of the reaction to ethyl 2-(((S)-1-
(benzyloxy)propan-2-yl)oxy)propanoate 15 and ethyl 2-ethoxypropanoate as 
main products. The products were purified by flash chromatography to give two 
diastereoisomers in a 1:1 ratio, which were not separable by flash 
chromatography. Yield: 0.628, 59%.  
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5.3.5 Synthesis of 2-(((S)-1-(benzyloxy)propan-2-yl)oxy)propan-1-ol 16 and 
chromatographic separation of its diastereoisomers (S, R)-17 and (S, S)-17.  
 
15 (3.70 g, 13.9 mmol) was dissolved in anhydrous THF (100 mL). This solution 
was added dropwise to a cooled suspension of LiAlH4 (0.53 g, 13.9 mmol) in 
anhydrous THF (20 mL), maintaining the temperature at approximately 20ºC. 
The suspension was then heated to reflux temperature (66 ºC) and the reaction 
was monitored by TLC. After two hours, the suspension was cooled with an ice 
bath. The reaction was slowly quenched with a saturated aqueous NH4Cl 
solution and left under stirring for one hour. The organic phase was separated 
and filtered. The remaining solid was washed with CH2CH2 (20 mL) and the 
organic phase was then concentrated. The resulting solid was redissolved in 
CH2Cl2 and consecutively washed with water and brine. The solution was finally 
dried with Na2SO4 and concentrated. The diastereoisomers were successfully 
separated by flash chromatography (30% EtOAc in n-hexane).  
First eluted isomer (S,R)-17 (418 mg, 49%).  
1H NMR 600 MHz (CDCl3): δ ppm 7.36-7.26 (m, 5H), 4.59 (d, J = 12.1 Hz, 1H), 
4.53 (d, J = 12.1 Hz, 1H), 3.82 (m, 1H), 3.65 (m, 1H), 3.55 (m, 2H), 3.45-3.38 
(m, 3H), 1.11 (d, J = 6.5 Hz, 6H).  
13C NMR 150 MHz (CDCl3): δ ppm 137.5, 128.4, 127.72, 127.67, 76.6, 74.9, 
74.5, 73.3, 67.0, 18.1, 17.9. 
Second eluted isomer (S,S)-17 (413 mg, 48.7%); [α]D
25 = +39.6 (c 1.14, CHCl3).  
1H NMR 600 MHz (CDCl3): δ ppm 7.37-7.25 (m, 5H), 4.57 (d, J = 12.1 Hz, 1H) , 
4.53 (d, J = 12.1 Hz, 1H), 3.80 (m, 1H), 3.71 (m, 1H), 3.54-3.41 (m, 2H), 3.47 
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(dd, J = 10.0 and 6.6 Hz, 1H), 3.38 (dd, 10.0 and 4.5 Hz, 1H), 2.56 (bs, 1H), 
1.16 (d, J = 6.3 Hz, 3H), 1.11 (d, J = 6.3 Hz, 3H).      
13C NMR 150 MHz (CDCl3): δ ppm 138.1, 128.3, 127.5 (two C’s), 74.3, 73.9, 
73.2, 71.8, 66.2, 17.6, 16.6.   
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5.3.6 Synthesis of (2S,2'R)-2,2'-oxybis(propan-1-ol) (S,R)-18 and (2S,2'S)-2,2'-
oxybis(propan-1-ol (S,S)-18.  
 
The reactions were carried out in with a shaker hydrogenation apparatus (Parr) 
and monitored by.  
Reaction 1: (S,R)-17: 330 mg, 1.05 mmol; catalyst: 5% Pd/C (50 mg); pressure: 
2 bar; solvent: CH3OH (10 mL); total reaction time: 24 hours. Yield: 130 mg, 
92%. 
 1H NMR 600 MHz (CDCl3): δ ppm 4.00 (bs, 2H), 3.66 (m, 2H), 3.60 (dd, J = 
11.5 and 2.9 Hz, 1H), 3.48 (dd, J = 11.5 and 8.1 Hz, 2H), 1.11 (d, J = 6.4 Hz, 
6H).  
13C NMR 150 MHz (CDCl3): δ ppm 76.3, 66.7, 17.8. 
 
Reaction 2: (S,S)-17: 899 mg, 4.0 mmol; catalyst: 5% Pd/C (200 mg); pressure: 
2 bar; solvent: CH3OH (30 mL); total reaction time: 14 hours. Yield: 461 mg, 
86%; [α]D
25 = +86.8 (c 1.35, CHCl3).  
1H NMR 600 MHz (CDCl3): δ ppm 3.71 (m, 2H), 3.56 (dd, J = 11.5 and 3.2 Hz, 
2H), 3.47 (dd, J = 11.5 and 7,3 Hz, 2H), 2.86 (bs, 2H), 1.13 (d, J = 6.2, 6H).  
13C NMR 150 MHz (CDCl3): δ ppm 73.0, 66.4, 16.1.   
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5.3.7 Syntheses of (2S,2'R)-oxybis(propane-2,1-diyl) bis(4-
methylbenzenesulfonate) (S,R)-19 and (2S,2'S)-oxybis(propane-2,1-diyl) bis(4-
methylbenzenesulfonate) (S,S)-19. 
 
Reaction 1: TsCl (953 mg, 5 mmol) was added to a solution of (S,R)-18 (142 
mg, 1.05 mmol) in anhydrous pyridine (2 mL) under stirring and cooled with an 
ice bath. The reaction was kept at approximately 4ºC for 48 hours. Water/ice 
(15 mL) was then added and the reaction remained under stirring for 60 
minutes. The resulting product was not filterable, so it was extracted with 
CH2Cl2 (4 x 5 mL). HCl 3M aq. (8 mL) was added under vigorous agitation in 
order to allow the elimination of excess pyridine from the organic phase. The 
organic phase was consecutively washed with water (3 x 5 mL) and brine (3 
mL), dried with MgSO4 and concentrated. The product was purified by flash 
chromatography (20% EtOAc in petroleum ether). Yield 412 mg, 88.6%.  
1H NMR 400 MHz (CDCl3): δ ppm 7.78 (m, 4H), 7.35 (m, 4H), 3.81 (dd, J = 10.2 
and 4.5 Hz, 2H), 3.87 (dd, J = 10.2 and 6.2 Hz, 2H), 2.71 (m, 2H), 2.45 (s, 6H), 
1.06 (d, J = 6.4 Hz, 6H). 
13C NMR 100 MHz (CDCl3): δ ppm 145.0, 132.8, 129.9, 127.9, 72.6, 72.0, 21.6, 
17.5.  
 
Reaction 2: TsCl (1.89 g, 9.9 mmol) was added to a solution of (S,S)-18 (440 
mL, 3.3 mmol) in anhydrous pyridine (3.3 mL) under stirring and cooled with an 
ice bath. The reaction was kept at approximately 4ºC for 48 hours. Water/ice 
(10 mL) was then added and the reaction remained under stirring for 60 
minutes. Differently from the reaction with the (S, R) diastereoisomer, a solid 
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was formed. After filtration, the solid was washed with HCl 2M aq. (2 mL), water 
(2 x 2 mL) and brine (2 mL). The solution was then dried with MgSO4. The 
product was crystallized in 5 mL of methanol. Yield: 1.25 g, 86%; mp = 78-80 
ºC; [α]D
23 = +3.8 (c 1.30, CHCl3).  
 1H NMR 400 MHz (CDCl3): δ ppm 7.77 (m, 4H), 7.34 (m, 4H), 3.85 (m, 4H), 
7.74 (m, 2H), 2.45 (s, 6H), 1.04 (d, J = 6.3 Hz, 6H). 
13C NMR 100 MHz (CDCl3): δ ppm 144.9, 132.9, 129.8, 127.9, 73.0, 72.5, 21.6, 
17.1.        
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5.3.8 Syntheses of (S)-1-iodo-2-(((R)-1-iodopropan-2-yl)oxy)propane (S,R)-20 
and (S)-1-iodo-2-(((S)-1-iodopropan-2-yl)oxy)propane (S,S)-20.   
 
Reaction 1: (S,R)-19 (206 mg, 0.47 mmol) was added to a saturated solution of 
NaI (279 mg, 1.86 mmol) in acetone (1 mL), which was then heated to 60ºC. 
After 18 hours, the suspension was diluted with Et2O (15 mL). The resulting 
solution was washed with water (2 x 3 mL) and brine (3 mL) and dried with 
MgSO4. Yield: 140 mg, 85%. 
1H NMR 400 MHz (CDCl3): δ ppm 3.58 (m, 4H), 3.28 (dd, J = 10.1 and 5.2 Hz, 
2H), 3.16 (dd, J = 10.1 and 6.2, 2H), 1.29 (d, J = 6.1, 6H). 
13C NMR 100 MHz (CDCl3): δ ppm 73.8, 20.8, 11.2.  
Reaction 2: (S,S)-19 (1.20 g, 2.84 mmol) was added to a saturated solution of 
NaI (1.5 g, 10 mmol) in acetone (3.5 mL) under stirring and nitrogen. Heated to 
50ºC for 14 hours. The suspension was then cooled diluted with Et2O (40 mL). 
The resulting solution was washed with water (2 x 4 mL) and brine (4 mL) and 
dried on MgSO4. The residue, after solvent evaporation, was purified by flash 
chromatography. Yield: 855 mg, 85%; [α]D
23 = +11.0 (c 2.0, CHCl3).    
1H NMR 400 MHz (CDCl3): δ ppm 3.57 (m, 2H), 3.21 (dd, J = 10.2 and 5.2 Hz, 
2H), 3.16 (dd, J = 10.2 and 5.9 Hz, 2H), 1.32 (d, J = 6.1 Hz, 6H). 
13C NMR 100 MHz (CDCl3): δ ppm 73.8, 21.1, 11.3.     
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5.3.9 Syntheses of (2S,6S)-4-((S)-3-(4-(tert-butyl)phenyl)-2-methylpropyl)-2,6-
dimethylmorpholine trans-(S)-21 and (2S,6R)-4-((S)-3-(4-(tert-butyl)phenyl)-2-
methylpropyl)-2,6-dimethylmorpholine cis-(S)-21. 
 
Reaction 1: (S,R)-20 (140 mg, 0.40 mmol) and K2CO3 (107 mg, 0.78 mmol) 
were consecutively added to a solution of (R)-25a (75 mg, 0.36 mmol) in 
anhydrous CH3CN (1 mL). The reaction was heated to 70 ºC and monitored by 
TLC. After 20 hours, the reaction was cooled and CH2Cl2 (15 mL) was added. 
The organic phase was washed with water (2 x 2 mL) and brine (2 mL), dried 
and concentrated. The product was purified by flash chromatography. Yield 90 
mg, 82%; [α]D
25 = -1.2 (c 1.32, CHCl3). 
1H NMR 400 MHz (CDCl3): δ ppm 7,28 (m, 2H), 7.08 (m, 2H), 3.67 (m, 2H), 
2.76 (dd, J = 13.4 and 4.7 Hz, 1H), 2.70 (m, 1H), 2.66 (m, 1H), 2.28 (dd, J = 
13.4 and 8.6 Hz, 1H), 2.18 (dd, J = 12.2 and 7.2 Hz, 1H), 2.09 (dd, J = 12.2 and 
7.5 Hz, 1H), 1.79 (m, 1H), 1.69 (m, 1H), 1.66 (m, 1H), 1.31 (s, 9H), 1.150 (d, J = 
6.2 Hz, 3H), 1.147 (d, 6.2 Hz, 3H), 0.85 (d, 6.4 Hz, 3H). 
13C NMR 100 MHz (CDCl3): δ ppm 148.4, 137.9, 128.8, 124.9, 71.71, 71.68, 
65.0, 60.1, 59.9, 40.7, 34.3, 32.0, 31.4, 19.2, 18.0. 
Mass spectrometry: ESI-MS, MeOH, positive ion scan, [M+H]+ 304 m/z 100%, 
[M+Na]+ 326 m/z 22%.          
Reaction 2: (S,S)-20 (179 mg, 0.50 mmol) and K2CO3 (138 mg, 1 mmol) were 
consecutively added to a solution of (R)-25a (95 mg, 0.46 mmol) in anhydrous 
CH3CN (1 mL). The reaction was heated to 70 ºC and monitored by TLC. After 
20 hours, the reaction was cooled and CH2Cl2 (15 mL) was added. The organic 
phase was washed with water (2 x 2 mL) and brine (2 mL), dried and 
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concentrated. The product was purified by flash chromatography. Yield: 126 
mg, 90%; [α]D
23 = -11.8 (c 1.40, CHCl3). 
1H NMR 400 MHz (CDCl3): δ ppm 7.28 (m, 2H), 7.08 (m, 2H), 4.00 (m, 2H), 
2.75 (dd, J = 13.5 and 4.9 Hz, 1H), 2.42 (m, 2H), 2.32 (dd, J = 13.5 and 8.2 Hz, 
1H), 2.15-2.08 (m, 3H), 2.05 (m, 1H), 1.94 (m, 1H), 1.31 (s, 9H), 1.23 (d, J = 6.5 
Hz, 6H), 0.86 (d, J = 6.7 Hz, 3H). 
13C NMR 600 MHz (CDCl3): δ ppm 148.4, 137.9, 128.9, 124.9, 66.8, 65.0, 59.2, 
40.7, 34.3, 32.1, 31.4, 18.2, 17.9.  
Mass spectrometry: ESI-MS, MeOH, positive ion scan, [M+H]+ 304 m/z 53%, 
[M+Na]+ 326 m/z 100%.          
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